A Study in Healthy Men to Test the Effects of Different Doses of BI 1467335 on MAO-B Activity in the Brain.
Clinical trial NCT03927209 · COMPLETED
Trial details
- NCT number
- NCT03927209
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-06
- Primary completion
- 2019-11-22
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.